Dr. Vimal Mehta
How Do Indian Doctors Deal with Dyslipidemia? LAI National Survey
- Uniformity in the use of dyslipidemia guidelines to be emphasized as patients in India often consult many physicians over time: to avoid contradictory advice that negatively impacts adherence.
- There is a need to educate physicians regarding familial hypercholesterolemia (FH) diagnosis and its importance.
- The incidence of statin intolerance is low, so statin usage should increase.
- Statins should be started at the time of diabetes mellitus diagnosis.
- The usage of nonstatin drugs is very low.
- Fibrates are still preferred in patients with high TG.
- Lp(a) estimation rates are low.
- It is encouraging that 60% have read about LAI guidelines.
Dr. Vimal Mehta
Prof Dr. Vimal Mehta is the Co-Founder & Chief Executive Officer at BioXcel Therapeutics & CEO, Chairman and Co-Founder. He Published a State of art paper in the Archives of Medical Science reviewing Pulmonary hypertension in left heart disease. Dr. Mehta holds a Ph.D. in chemistry from the University of Delhi, India and completed a Post-Doctoral Fellowship in chemistry at the University of Montpellier, France.
More FAQs by Dr. Vimal Mehta
Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks
Please login to comment on this article